http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114533755-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d890ad239375a780e6827d3407f15ef3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0003
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2022-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fd4477849a7b0c57962a788b8fe1df9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_169c86d8b18be0d50fbf0d61edd835e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_768458756caef90011f67752940430ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afc0721c1af1d490e129507449c17d1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5539bd2cb17cb6fa10428f0e95dad76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d25052854f16f5081bbebf2aabe5766f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7791374cd2f7e40bb242be45bb88970e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ec2d453c2860030223b3f78cdf232f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87605815ab33c9f6e5a33a46b2a4f6dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c033c45c4220aac917c2c31fc2437e5a
publicationDate 2022-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114533755-A
titleOfInvention Application of Gynostemma polysaccharide and indirubin in anti-melanoma drugs
abstract This scheme relates to the field of drug research, in particular to the application of Gynostemma polysaccharide and indirubin in anti-melanoma drugs. Said Gynostemma polysaccharide is obtained by extracting and ethanol precipitation from Gynostemma stems and leaves, and lyophilizing the precipitate. , including rhamnose, mannose, arabinose, glucuronic acid, galactose and glucose. The total polysaccharide of Gynostemma pentaphyllum can assist indirubin in inhibiting melanoma, and significantly reduce the half-inhibitory concentration of indirubin in inhibiting melanoma. Therefore, the total polysaccharide of Gynostemma pentaphyllum and indirubin can form a pharmaceutical composition for treating melanoma.
priorityDate 2022-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21663959
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456490784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453739895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412630177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5770

Total number of triples: 49.